Copyright Reports & Markets. All rights reserved.

Europe Peptide Vaccine Market Report 2018

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Peptide Vaccine Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Biomarkers Market Performance (Volume)
      • 2.1.2 NY-ESO-1 Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.1.1 Biomarkers Market Performance (Value)
      • 2.1.2 NY-ESO-1 Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Prostate Cancer Market Performance (Volume)
      • 3.1.2 Breast Cancer Market Performance (Volume)
      • 3.1.3 Gastric Cancer Market Performance (Volume)
      • 3.1.4 Lung Cancer Market Performance (Volume)
      • 3.1.5 Pancreatic Cancer Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 AFFiRiS
      • 4.1.1 AFFiRiS Profiles
      • 4.1.2 AFFiRiS Product Information
      • 4.1.3 AFFiRiS Peptide Vaccine Business Performance
      • 4.1.4 AFFiRiS Peptide Vaccine Business Development and Market Status
    • 4.2 AlerGenetica
      • 4.2.1 AlerGenetica Profiles
      • 4.2.2 AlerGenetica Product Information
      • 4.2.3 AlerGenetica Peptide Vaccine Business Performance
      • 4.2.4 AlerGenetica Peptide Vaccine Business Development and Market Status
    • 4.3 Anergis
      • 4.3.1 Anergis Profiles
      • 4.3.2 Anergis Product Information
      • 4.3.3 Anergis Peptide Vaccine Business Performance
      • 4.3.4 Anergis Peptide Vaccine Business Development and Market Status
    • 4.4 Antigen Express
      • 4.4.1 Antigen Express Profiles
      • 4.4.2 Antigen Express Product Information
      • 4.4.3 Antigen Express Peptide Vaccine Business Performance
      • 4.4.4 Antigen Express Peptide Vaccine Business Development and Market Status
    • 4.5 Apitope Technology
      • 4.5.1 Apitope Technology Profiles
      • 4.5.2 Apitope Technology Product Information
      • 4.5.3 Apitope Technology Peptide Vaccine Business Performance
      • 4.5.4 Apitope Technology Peptide Vaccine Business Development and Market Status
    • 4.6 Araclon Biotech
      • 4.6.1 Araclon Biotech Profiles
      • 4.6.2 Araclon Biotech Product Information
      • 4.6.3 Araclon Biotech Peptide Vaccine Business Performance
      • 4.6.4 Araclon Biotech Peptide Vaccine Business Development and Market Status
    • 4.7 Artificial Cell Technologies
      • 4.7.1 Artificial Cell Technologies Profiles
      • 4.7.2 Artificial Cell Technologies Product Information
      • 4.7.3 Artificial Cell Technologies Peptide Vaccine Business Performance
      • 4.7.4 Artificial Cell Technologies Peptide Vaccine Business Development and Market Status
    • 4.8 Benovus Bio
      • 4.8.1 Benovus Bio Profiles
      • 4.8.2 Benovus Bio Product Information
      • 4.8.3 Benovus Bio Peptide Vaccine Business Performance
      • 4.8.4 Benovus Bio Peptide Vaccine Business Development and Market Status
    • 4.9 Bionor Pharma
      • 4.9.1 Bionor Pharma Profiles
      • 4.9.2 Bionor Pharma Product Information
      • 4.9.3 Bionor Pharma Peptide Vaccine Business Performance
      • 4.9.4 Bionor Pharma Peptide Vaccine Business Development and Market Status
    • 4.10 Circassia
      • 4.10.1 Circassia Profiles
      • 4.10.2 Circassia Product Information
      • 4.10.3 Circassia Peptide Vaccine Business Performance
      • 4.10.4 Circassia Peptide Vaccine Business Development and Market Status
    • 4.11 Celgene Corporation
    • 4.12 Galena Biopharma
    • 4.13 Anergis
    • 4.14 Antigen Express
    • 4.15 Apitope Technology

    5 Market Performance for Manufacturers

    • 5.1 Europe Peptide Vaccine Sales (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 Europe Peptide Vaccine Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 Europe Peptide Vaccine Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 Europe Peptide Vaccine Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 Germany Market Performance for Manufacturers
      • 6.1.1 Germany Peptide Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.1.2 Germany Peptide Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.1.3 Germany Peptide Vaccine Price (USD/Unit) of Manufacturers 2013-2018
      • 6.1.4 Germany Peptide Vaccine Gross Margin of Manufacturers 2013-2018
      • 6.1.5 Market Concentration
    • 6.2 UK Market Performance for Manufacturers
      • 6.2.1 UK Peptide Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.2.2 UK Peptide Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.2.3 UK Peptide Vaccine Price (USD/Unit) of Manufacturers 2013-2018
      • 6.2.4 UK Peptide Vaccine Gross Margin of Manufacturers 2013-2018
      • 6.2.5 Market Concentration
    • 6.3 France Market Performance for Manufacturers
      • 6.3.1 France Peptide Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.3.2 France Peptide Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.3.3 France Peptide Vaccine Price (USD/Unit) of Manufacturers 2013-2018
      • 6.3.4 France Peptide Vaccine Gross Margin of Manufacturers 2013-2018
      • 6.3.5 Market Concentration
    • 6.4 Russia Market Performance for Manufacturers
      • 6.4.1 Russia Peptide Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.4.2 Russia Peptide Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.4.3 Russia Peptide Vaccine Price (USD/Unit) of Manufacturers 2013-2018
      • 6.4.4 Russia Peptide Vaccine Gross Margin of Manufacturers 2013-2018
      • 6.4.5 Market Concentration
    • 6.5 Benelux Market Performance for Manufacturers
      • 6.5.1 Benelux Peptide Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.5.2 Benelux Peptide Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.5.3 Benelux Peptide Vaccine Price (USD/Unit) of Manufacturers 2013-2018
      • 6.5.4 Benelux Peptide Vaccine Gross Margin of Manufacturers 2013-2018
      • 6.5.5 Market Concentration
    • 6.6 Italy Market Performance for Manufacturers
      • 6.6.1 Italy Peptide Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.6.2 Italy Peptide Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.6.3 Italy Peptide Vaccine Price (USD/Unit) of Manufacturers 2013-2018
      • 6.6.4 Italy Peptide Vaccine Gross Margin of Manufacturers 2013-2018
      • 6.6.5 Market Concentration
    • 6.7 Spain Market Performance for Manufacturers
      • 6.7.1 Spain Peptide Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.7.2 Spain Peptide Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.7.3 Spain Peptide Vaccine Price (USD/Unit) of Manufacturers 2013-2018
      • 6.7.4 Spain Peptide Vaccine Gross Margin of Manufacturers 2013-2018
      • 6.7.5 Market Concentration
    • 6.8 Market Performance for Manufacturers
      • 6.8.1 Peptide Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.8.2 Peptide Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.8.3 Peptide Vaccine Price (USD/Unit) of Manufacturers 2013-2018
      • 6.8.4 Peptide Vaccine Gross Margin of Manufacturers 2013-2018
      • 6.8.5 Market Concentration

    7 Europe Peptide Vaccine Market Performance (Sales Point)

    • 7.1 Europe Peptide Vaccine Sales (K Units) and Market Share by Regions 2013-2018
    • 7.2 Europe Peptide Vaccine Revenue (M USD) and Market Share by Regions 2013-2018
    • 7.3 Europe Peptide Vaccine Price (USD/Unit) by Regions 2013-2018
    • 7.4 Europe Peptide Vaccine Gross Margin by Regions 2013-2018

    8 Development Trend for Regions (Sales Point)

    • 8.1 Europe Peptide Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.2 Germany Peptide Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.3 UK Peptide Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.4 France Peptide Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.5 Russia Peptide Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.6 Benelux Peptide Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.7 Italy Peptide Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Spain Peptide Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Spain Peptide Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Prostate Cancer Industry
    • 11.2 Breast Cancer Industry
    • 11.3 Gastric Cancer Industry

    12 Market Forecast 2019-2024

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 12.1.1 Europe Peptide Vaccine Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 12.1.2 Europe Peptide Vaccine Sales (K Units) and Growth Rate 2019-2024
      • 12.1.3 Germany Peptide Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.4 UK Peptide Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.5 France Peptide Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.6 Russia Peptide Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.7 Benelux Peptide Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.8 Italy Peptide Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.9 Spain Peptide Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
      • 12.3.1 Overall Market Performance
      • 12.3.2 Biomarkers Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.3 NY-ESO-1 Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.4 Sales by Application 2019-2024
      • 12.4.1 Overall Market Performance
      • 12.4.2 Prostate Cancer Sales and and Growth Rate 2019-2024
      • 12.4.3 Breast Cancer Sales and and Growth Rate 2019-2024
      • 12.4.4 Gastric Cancer Sales and and Growth Rate 2019-2024
      • 12.4.5 Lung Cancer Sales and and Growth Rate 2019-2024
    • 12.5 Price (USD/Unit) and Gross Profit
      • 12.5.1 Europe Peptide Vaccine Price (USD/Unit) Trend 2019-2024
      • 12.5.2 Europe Peptide Vaccine Gross Profit Trend 2019-2024

    13 Conclusion

    Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Peptide Vaccine for these regions, from 2012 to 2023 (forecast), including
    Germany
    UK
    France
    Russia
    Benelux
    Italy
    Spain

    Europe Peptide Vaccine market competition by top manufacturers/players, with Peptide Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    AFFiRiS
    AlerGenetica
    Anergis
    Antigen Express
    Apitope Technology
    Araclon Biotech
    Artificial Cell Technologies
    Benovus Bio
    Bionor Pharma
    Circassia
    Celgene Corporation
    Galena Biopharma
    Immatics biotechnologies
    Immune Design
    ImmunoCellular Therapeutics

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Biomarkers
    NY-ESO-1

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Peptide Vaccine for each application, including
    Prostate Cancer
    Breast Cancer
    Gastric Cancer
    Lung Cancer
    Pancreatic Cancer

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now